Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)
Public ClinicalTrials.gov record NCT01939002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Two-Arm Randomized Study to Characterize Flu-Like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Current Interferon Beta Therapies to BIIB017
Study identification
- NCT ID
- NCT01939002
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 251 participants
Conditions and interventions
Conditions
Interventions
- BIIB017 Drug
- naproxen Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2013
- Primary completion
- Sep 30, 2015
- Completion
- Oct 31, 2015
- Last update posted
- Jan 24, 2017
2013 – 2015
United States locations
- U.S. sites
- 38
- U.S. states
- 22
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Gilbert | Arizona | 85234 | — |
| Research Site | Phoenix | Arizona | 85004 | — |
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Tucson | Arizona | 85704 | — |
| Research Site | Boulder | Colorado | 80301 | — |
| Research Site | Fort Collins | Colorado | 80528 | — |
| Research Site | Dover | Delaware | 19901 | — |
| Research Site | Newark | Delaware | 19713 | — |
| Research Site | Jacksonville | Florida | 32209 | — |
| Research Site | Melbourne | Florida | 32901 | — |
| Research Site | Tampa | Florida | 33609 | — |
| Research Site | Atlanta | Georgia | 30327 | — |
| Research Site | Kansas City | Kansas | 66160 | — |
| Research Site | Lexington | Kentucky | 40513 | — |
| Research Site | Louisville | Kentucky | 40207 | — |
| Research Site | Boston | Massachusetts | 02135 | — |
| Research Site | Lexington | Massachusetts | 02421 | — |
| Research Site | Worcester | Massachusetts | 01655 | — |
| Research Site | Detroit | Michigan | 48202 | — |
| Research Site | Chesterfield | Missouri | 63017 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Great Falls | Montana | 59405 | — |
| Research Site | Lincoln | Nebraska | 68521 | — |
| Research Site | Latham | New York | 12110 | — |
| Research Site | Plainview | New York | 11803 | — |
| Research Site | Asheville | North Carolina | 28806 | — |
| Research Site | Akron | Ohio | 44320 | — |
| Research Site | Dayton | Ohio | 45417 | — |
| Research Site | Uniontown | Ohio | 44685 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Portland | Oregon | 97225 | — |
| Research Site | Greenville | South Carolina | 29607 | — |
| Research Site | Franklin | Tennessee | 37064 | — |
| Research Site | Knoxville | Tennessee | 37934 | — |
| Research Site | Salt Lake City | Utah | 84103 | — |
| Research Site | Newport News | Virginia | 23601 | — |
| Research Site | Roanoke | Virginia | 24018 | — |
| Research Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01939002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01939002 live on ClinicalTrials.gov.